By using four newly generated antibodies, MacFadyen et al. demonstrated that endosialin was predominantly expressed in fibroblasts and a subset of tumor vessel-associated pericytes but not in the tumor endothelium 17. The gene discussed is CD248; the disease is neoplasm.